Insider · CIK 0001555851

Rawcliffe Adrian

CIK 0001555851 Name as filed on the most recent filing

Filed as Rawcliffe Adrian (28)

34 transaction lines · from 28 filings · filed 2018-03-22 to 2026-08-13 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-26 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

34 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-26 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-08-12 S, Open-market sale Wave Life Sciences, Inc.WVE 67,183, disposed Open Form 4 filing 0001193125-26-349962
2025-12-08 S, Open-market sale Wave Life Sciences Ltd.WVE 630,000, disposed Open Form 4 filing 0001193125-25-314742
2025-11-13 S, Open-market sale Wave Life Sciences Ltd.WVE 109,421, disposed Open Form 4 filing 0001193125-25-283619
2025-01-17 S, Open-market sale Adaptimmune Therapeutics PLCADAP 17,773, disposed Open Form 4 filing 0001104659-25-004605
2025-01-15 S, Open-market sale Adaptimmune Therapeutics PLCADAP 16,724, disposed Open Form 4 filing 0001104659-25-003775
2025-01-13 S, Open-market sale Adaptimmune Therapeutics PLCADAP 2 lines 17,915, disposed Open Form 4 filing 0001104659-25-003775
2024-01-17 S, Open-market sale Adaptimmune Therapeutics PLCADAP 20,244, disposed Open Form 4 filing 0001104659-24-004564
2024-01-16 S, Open-market sale Adaptimmune Therapeutics PLCADAP 7,350, disposed Open Form 4 filing 0001104659-24-004564
2024-01-12 S, Open-market sale Adaptimmune Therapeutics PLCADAP 14,739, disposed Open Form 4 filing 0001104659-24-003742
2024-01-11 S, Open-market sale Adaptimmune Therapeutics PLCADAP 9,994, disposed Open Form 4 filing 0001104659-24-003742
2023-09-01 S, Open-market sale Adaptimmune Therapeutics PLCADAP 1,874, disposed Open Form 4 filing 0001104659-23-097853
2023-06-27 S, Open-market sale Adaptimmune Therapeutics PLCADAP 2,146, disposed Open Form 4 filing 0001104659-23-075407
2023-01-17 S, Open-market sale Adaptimmune Therapeutics PLCADAP 18,686, disposed Open Form 4 filing 0001104659-23-004379
2023-01-12 S, Open-market sale Adaptimmune Therapeutics PLCADAP 32,010, disposed Open Form 4 filing 0001104659-23-003534
2023-01-11 S, Open-market sale Adaptimmune Therapeutics PLCADAP 22,782, disposed Open Form 4 filing 0001104659-23-003534
2023-01-04 S, Open-market sale Adaptimmune Therapeutics PLCADAP 8,594, disposed Open Form 4 filing 0001104659-23-001088
2022-09-01 S, Open-market sale Adaptimmune Therapeutics PLCADAP 4,993, disposed Open Form 4 filing 0001104659-22-097135
2022-06-27 S, Open-market sale Adaptimmune Therapeutics PLCADAP 4,176, disposed Open Form 4 filing 0001104659-22-074926
2022-01-18 S, Open-market sale Adaptimmune Therapeutics PLCADAP 35,416, disposed Open Form 4 filing 0001104659-22-005053
2022-01-12 S, Open-market sale Adaptimmune Therapeutics PLCADAP 10,795, disposed Open Form 4 filing 0001104659-22-004149
2022-01-11 S, Open-market sale Adaptimmune Therapeutics PLCADAP 51,081, disposed Open Form 4 filing 0001104659-22-004149
2022-01-04 S, Open-market sale Adaptimmune Therapeutics PLCADAP 22,483, disposed Open Form 4 filing 0001104659-22-001668
2021-09-01 S, Open-market sale Adaptimmune Therapeutics PLCADAP 14,452, disposed Open Form 4 filing 0001104659-21-112179
2021-06-28 S, Open-market sale Adaptimmune Therapeutics PLCADAP 12,210, disposed Open Form 4 filing 0001104659-21-086385
2021-01-19 S, Open-market sale Adaptimmune Therapeutics PLCADAP 56,009, disposed Open Form 4 filing 0001104659-21-005544
2021-01-12 S, Open-market sale Adaptimmune Therapeutics PLCADAP 16,654, disposed Open Form 4 filing 0001104659-21-003590
2021-01-04 S, Open-market sale Adaptimmune Therapeutics PLCADAP 26,464, disposed Open Form 4 filing 0001104659-21-001175
2020-09-01 S, Open-market sale Adaptimmune Therapeutics PLCADAP 23,637, disposed Open Form 4 filing 0001104659-20-101976
2020-08-03 S, Open-market sale Adaptimmune Therapeutics PLCADAP 25,789, disposed Open Form 4 filing 0001104659-20-090468
2020-01-14 S, Open-market sale Adaptimmune Therapeutics PLCADAP 16,616, disposed Open Form 4 filing 0001104659-20-004420
2020-01-06 S, Open-market sale Adaptimmune Therapeutics PLCADAP 7,080, disposed Open Form 4 filing 0001104659-20-002080
2019-01-14 S, Open-market sale Adaptimmune Therapeutics PLCADAP 16,559, disposed Open Form 4 filing 0001104659-19-002163
2018-03-20 S, Open-market sale Adaptimmune Therapeutics PLCADAP 1,026,000, disposed Open Form 4 filing 0001104659-18-019665

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 34
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Rawcliffe Adrian, insider transactions. Retrieved 2026-08-26 from https://ebomi.com/insider/0001555851

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.